ICD-10-CM 2020 Search includes the entire 2020 code set for diagnostic coding in an easily searched always accessible web based platform.

Displaying 35501 - 35600 of 73384
Title
T43.93XA Poisoning by unspecified psychotropic drug, assault, initial encounter
T43.93XD Poisoning by unspecified psychotropic drug, assault, subsequent encounter
T43.93XS Poisoning by unspecified psychotropic drug, assault, sequela
T43.94XA Poisoning by unspecified psychotropic drug, undetermined, initial encounter
T43.94XD Poisoning by unspecified psychotropic drug, undetermined, subsequent encounter
T43.94XS Poisoning by unspecified psychotropic drug, undetermined, sequela
T43.95XA Adverse effect of unspecified psychotropic drug, initial encounter
T43.95XD Adverse effect of unspecified psychotropic drug, subsequent encounter
T43.95XS Adverse effect of unspecified psychotropic drug, sequela
T43.96XA Underdosing of unspecified psychotropic drug, initial encounter
T43.96XD Underdosing of unspecified psychotropic drug, subsequent encounter
T43.96XS Underdosing of unspecified psychotropic drug, sequela
T44.0X1A Poisoning by anticholinesterase agents, accidental (unintentional), initial encounter
T44.0X1D Poisoning by anticholinesterase agents, accidental (unintentional), subsequent encounter
T44.0X1S Poisoning by anticholinesterase agents, accidental (unintentional), sequela
T44.0X2A Poisoning by anticholinesterase agents, intentional self-harm, initial encounter
T44.0X2D Poisoning by anticholinesterase agents, intentional self-harm, subsequent encounter
T44.0X2S Poisoning by anticholinesterase agents, intentional self-harm, sequela
T44.0X3A Poisoning by anticholinesterase agents, assault, initial encounter
T44.0X3D Poisoning by anticholinesterase agents, assault, subsequent encounter
T44.0X3S Poisoning by anticholinesterase agents, assault, sequela
T44.0X4A Poisoning by anticholinesterase agents, undetermined, initial encounter
T44.0X4D Poisoning by anticholinesterase agents, undetermined, subsequent encounter
T44.0X4S Poisoning by anticholinesterase agents, undetermined, sequela
T44.0X5A Adverse effect of anticholinesterase agents, initial encounter
T44.0X5D Adverse effect of anticholinesterase agents, subsequent encounter
T44.0X5S Adverse effect of anticholinesterase agents, sequela
T44.0X6A Underdosing of anticholinesterase agents, initial encounter
T44.0X6D Underdosing of anticholinesterase agents, subsequent encounter
T44.0X6S Underdosing of anticholinesterase agents, sequela
T44.1X1A Poisoning by other parasympathomimetics [cholinergics], accidental (unintentional), initial encounter
T44.1X1D Poisoning by other parasympathomimetics [cholinergics], accidental (unintentional), subsequent encounter
T44.1X1S Poisoning by other parasympathomimetics [cholinergics], accidental (unintentional), sequela
T44.1X2A Poisoning by other parasympathomimetics [cholinergics], intentional self-harm, initial encounter
T44.1X2D Poisoning by other parasympathomimetics [cholinergics], intentional self-harm, subsequent encounter
T44.1X2S Poisoning by other parasympathomimetics [cholinergics], intentional self-harm, sequela
T44.1X3A Poisoning by other parasympathomimetics [cholinergics], assault, initial encounter
T44.1X3D Poisoning by other parasympathomimetics [cholinergics], assault, subsequent encounter
T44.1X3S Poisoning by other parasympathomimetics [cholinergics], assault, sequela
T44.1X4A Poisoning by other parasympathomimetics [cholinergics], undetermined, initial encounter
T44.1X4D Poisoning by other parasympathomimetics [cholinergics], undetermined, subsequent encounter
T44.1X4S Poisoning by other parasympathomimetics [cholinergics], undetermined, sequela
T44.1X5A Adverse effect of other parasympathomimetics [cholinergics], initial encounter
T44.1X5D Adverse effect of other parasympathomimetics [cholinergics], subsequent encounter
T44.1X5S Adverse effect of other parasympathomimetics [cholinergics], sequela
T44.1X6A Underdosing of other parasympathomimetics [cholinergics], initial encounter
T44.1X6D Underdosing of other parasympathomimetics [cholinergics], subsequent encounter
T44.1X6S Underdosing of other parasympathomimetics [cholinergics], sequela
T44.2X1A Poisoning by ganglionic blocking drugs, accidental (unintentional), initial encounter
T44.2X1D Poisoning by ganglionic blocking drugs, accidental (unintentional), subsequent encounter
T44.2X1S Poisoning by ganglionic blocking drugs, accidental (unintentional), sequela
T44.2X2A Poisoning by ganglionic blocking drugs, intentional self-harm, initial encounter
T44.2X2D Poisoning by ganglionic blocking drugs, intentional self-harm, subsequent encounter
T44.2X2S Poisoning by ganglionic blocking drugs, intentional self-harm, sequela
T44.2X3A Poisoning by ganglionic blocking drugs, assault, initial encounter
T44.2X3D Poisoning by ganglionic blocking drugs, assault, subsequent encounter
T44.2X3S Poisoning by ganglionic blocking drugs, assault, sequela
T44.2X4A Poisoning by ganglionic blocking drugs, undetermined, initial encounter
T44.2X4D Poisoning by ganglionic blocking drugs, undetermined, subsequent encounter
T44.2X4S Poisoning by ganglionic blocking drugs, undetermined, sequela
T44.2X5A Adverse effect of ganglionic blocking drugs, initial encounter
T44.2X5D Adverse effect of ganglionic blocking drugs, subsequent encounter
T44.2X5S Adverse effect of ganglionic blocking drugs, sequela
T44.2X6A Underdosing of ganglionic blocking drugs, initial encounter
T44.2X6D Underdosing of ganglionic blocking drugs, subsequent encounter
T44.2X6S Underdosing of ganglionic blocking drugs, sequela
T44.3X1A Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), initial encounter
T44.3X1D Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), subsequent encounter
T44.3X1S Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), sequela
T44.3X2A Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, initial encounter
T44.3X2D Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, subsequent encounter
T44.3X2S Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, sequela
T44.3X3A Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, initial encounter
T44.3X3D Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, subsequent encounter
T44.3X3S Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, sequela
T44.3X4A Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, initial encounter
T44.3X4D Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, subsequent encounter
T44.3X4S Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, sequela
T44.3X5A Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter
T44.3X5D Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter
T44.3X5S Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela
T44.3X6A Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter
T44.3X6D Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter
T44.3X6S Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela
T44.4X1A Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), initial encounter
T44.4X1D Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), subsequent encounter
T44.4X1S Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), sequela
T44.4X2A Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, initial encounter
T44.4X2D Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, subsequent encounter
T44.4X2S Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, sequela
T44.4X3A Poisoning by predominantly alpha-adrenoreceptor agonists, assault, initial encounter
T44.4X3D Poisoning by predominantly alpha-adrenoreceptor agonists, assault, subsequent encounter
T44.4X3S Poisoning by predominantly alpha-adrenoreceptor agonists, assault, sequela
T44.4X4A Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, initial encounter
T44.4X4D Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, subsequent encounter
T44.4X4S Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, sequela
T44.4X5A Adverse effect of predominantly alpha-adrenoreceptor agonists, initial encounter
T44.4X5D Adverse effect of predominantly alpha-adrenoreceptor agonists, subsequent encounter
T44.4X5S Adverse effect of predominantly alpha-adrenoreceptor agonists, sequela
T44.4X6A Underdosing of predominantly alpha-adrenoreceptor agonists, initial encounter